NovaBridge Biosciences (NBP) Goodwill & Intangibles (2018 - 2023)

NovaBridge Biosciences (NBP) has 6 years of Goodwill & Intangibles data on file, last reported at $16.4 million in Q4 2023.

• Goodwill & Intangibles for Q4 2023 came in at $16.4 million, down 58.55% year-over-year; the trailing twelve-month figure through Dec 2023 was $16.4 million (down 58.55% YoY), and the FY2023 annual result was $16.4 million, down 99.96% from the prior year.
• Goodwill & Intangibles eased to $16.4 million in Q4 2023 per NBP's latest filing, from $40.1 million in the prior quarter.
• Over five years, Goodwill & Intangibles peaked at $44.1 billion in Q4 2021 and troughed at $16.4 million in Q4 2023.
• A 5-year average of $4.4 billion and a median of $42.7 million in 2020 frame the typical range for Goodwill & Intangibles.
• The sharpest annual moves came in 2021 and 2022: Goodwill & Intangibles jumped 103270.82% in 2021, then plunged 99.91% in 2022.
• A 5-year view of Goodwill & Intangibles shows it stood at $44.2 million in 2019, then retreated by 3.35% to $42.7 million in 2020, then jumped by 103270.82% to $44.1 billion in 2021, then tumbled by 99.91% to $39.6 million in 2022, then sank by 58.55% to $16.4 million in 2023.
• Business Quant data shows NBP's Goodwill & Intangibles at $16.4 million in Q4 2023, $40.1 million in Q2 2023, and $39.6 million in Q4 2022.